Bacterial Pneumonia Therapeutics Market: Next-Generation Antibiotics, Conjugate Vaccines, and Rapid Molecular Diagnostics Driving Growth
Persistent global morbidity from lower respiratory tract infections, rising hospitalization and ventilator-associated pneumonia rates among elderly and immunocompromised populations, and escalating threats from multidrug-resistant (MDR) bacterial pathogens are driving sustained growth across the global Bacterial Pneumonia Therapeutics Market. Bacterial pneumonia therapeutics—comprising...
0 Comments 0 Shares 2 Views 0 Reviews